Emerging therapeutic targets in asthma: the rationale for mast cell tryptase inhibition

This publication has 55 references indexed in Scilit:

• Human Mast Cell Tryptase Fibrinogenolysis: Kinetics, Anticoagulation Mechanism, and Cell Adhesion Disruption
  Biochemistry, 1998
• Esophageal Candidiasis as a Complication of Inhaled Corticosteroids
  Annals of Allergy, Asthma & Immunology, 1997
• Structural Changes Associated with the Spontaneous Inactivation of the Serine Proteinase Human Tryptase
  Biochemistry, 1995
• Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma
  European Respiratory Journal, 1994
• Effect of inhaled corticosteroids on peripheral blood eosinophil counts and density profiles in asthma
  Journal of Allergy and Clinical Immunology, 1993
• Mast cell tryptase is a mitogen for cultured fibroblasts.
  Journal of Clinical Investigation, 1991
• The Role of Eosinophils in the Pathophysiology of Asthma^a
  Annals of the New York Academy of Sciences, 1991
• Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits
  Journal of Allergy and Clinical Immunology, 1989
• Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs.
  Journal of Clinical Investigation, 1989
• Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and Mastocytosis
  New England Journal of Medicine, 1987